mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.057 |
0.3 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.3 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.3 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |